NYSE:BHVNBiotechs
Is Biohaven (BHVN) Undervalued Following Its Latest Earnings Loss Improvement?
Biohaven earnings update and what it means for investors
Biohaven (BHVN) reported second quarter 2026 results that showed a reduced net loss of US$137.31 million. Loss per share from continuing operations was US$0.91, compared with US$1.94 a year earlier.
For the first half of 2026, Biohaven reported a net loss of US$267.84 million, with basic loss per share from continuing operations of US$1.80, compared with US$4.11 in the prior year period.
See our latest analysis for Biohaven.
Biohaven’s...